Last updated: July 17, 2026

Application No. 18/290,259

ENGINEERING STEM CELLS FOR ALLOGENIC CAR T CELL THERAPIES

Non-Final OA

Filed

Nov 10, 2023

Priority

May 14, 2021 — provisional 63/188,872 +1 more

Examiner

LY, KRISTINA ELISABETH

Art Unit

1671

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Regents of the University of California

OA Round

1 (Non-Final)

This examiner grants 50% of cases after interview

— +100.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 4 resolved cases, 2023–2026

Examiner Intelligence

LY, KRISTINA ELISABETH View full profile →

Grants 50% of resolved cases

Career Allowance Rate

2 granted / 4 resolved

-10.0% vs TC avg

Strong +100% interview lift

Without

With

+100.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

46 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

1.6%

-38.4% vs TC avg

§103

54.0%

+14.0% vs TC avg

§102

3.2%

-36.8% vs TC avg

§112

27.0%

-13.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 4 resolved cases

Prosecution Timeline

Nov 10, 2023

Application Filed

Apr 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/223,230

Patent 12655396

CONSTRUCTION AND APPLICATION OF RECOMBINANT H5N8 SUBTYPE AVIAN INFLUENZA VIRUS CARRYING MAPPLE FLUORESCENCE REPORTER GENE

2y 11m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 1 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

50%

Grant Probability

99%

With Interview (+100.0%)

3y 0m (~3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 4 resolved cases by this examiner. Grant probability derived from career allowance rate.